Form 4/A for MAIA MAIA Biotechnology, Inc.
Accepted 2025-12-04 00:00:00 ET · period of report 2025-11-25 · accession 0001878313-25-000060 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2025-12-04 | 2025-11-25 | MAIA | Vitoc Vlad | CEO, Dir, 10% | P - Purchase | $0.97 | +10.5K | 831.4K | +1% | +$10.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-25 | P | A | 10,500 | $0.97 | 831,421 | D | — | — |